Page 7 of 20

PA11.1-3 | Genetic & Pediatric Diseases — SDL Guide (Part 3)

Retinoblastoma, Ewing Sarcoma & Rhabdomyosarcoma

Three-panel educational diagram explaining retinoblastoma genetics, clinical presentation, and histological rosettes.

Retinoblastoma: Genetics, Clinical Features and Histology

Panel A: RB1 tumor suppressor gene, chromosome 13q14, first hit, second hit, hereditary retinoblastoma, sporadic retinoblastoma, bilateral multifocal tumors, unilateral unifocal tumor, osteosarcoma risk. Panel B: Leukocoria, white pupillary reflex, cat's eye reflex, strabismus, typical age 1-3 years. Panel C: Small round blue cells, Flexner-Wintersteiner rosette, central lumen, photoreceptor differentiation, Homer-Wright rosette, central fibrillary neuropil.

Retinoblastoma

Most common intraocular tumour of childhood. Caused by mutation/deletion of both alleles of the RB1 tumour suppressor gene (chromosome 13q14), the prototype for Knudson's two-hit hypothesis:
- Hereditary (40%): first hit = germline mutation (inherited or de novo), second hit = somatic mutation in any retinal cell → bilateral/multifocal tumours; AD inheritance; also risk of osteosarcoma later.
- Sporadic (60%): both hits somatic → unilateral, unifocal.

Clinical: leukocoria (white pupillary reflex, "cat's eye reflex") in a child aged 1–3 years; strabismus.

Morphology: small round blue cells; Flexner-Wintersteiner rosettes (true rosette — cells surrounding a central lumen, mimicking photoreceptor differentiation); Homer-Wright rosettes also seen.

Ewing Sarcoma

t(11;22)(q24;q12) producing EWSR1-FLI1 fusion gene → aberrant transcription factor. Arises in bone diaphysis (midshaft) of long bones; also chest wall (Askin tumour).

Morphology: monotonous sheets of small round blue cells with clear cytoplasm (glycogen — PAS+); no rosettes. "Onion-skin" periosteal reaction on X-ray.

Rhabdomyosarcoma

Most common soft-tissue sarcoma of childhood; shows skeletal muscle differentiation.
- Embryonal (most common, better prognosis): grape-like (sarcoma botryoides in hollow organs), spindle cells, loss of heterozygosity at 11p15.
- Alveolar (worse prognosis): t(2;13) → PAX3-FOXO1 fusion; alveolar spaces mimicking lung.

Markers: desmin, vimentin, MyoD1 (myogenic transcription factor), myogenin — confirm rhabdomyoblastic differentiation even without cross-striations.

CLINICAL PEARL

"Small round blue cell" differential — your discriminator checklist:

  1. Site: adrenal/paraspinal → neuroblastoma; kidney → Wilms; retina → retinoblastoma; bone diaphysis → Ewing; soft tissue/head/neck → rhabdomyosarcoma.
  2. Rosette type: Homer-Wright (neuroblastoma, no lumen) vs. Flexner-Wintersteiner (retinoblastoma, has lumen).
  3. Urine catecholamines: ↑VMA/HVA → neuroblastoma.
  4. IHC panel: desmin+/MyoD1+ → rhabdomyosarcoma; NB84/NSE/synaptophysin → neuroblastoma; WT1+ → Wilms blastemal component; CD99 (MIC2)+ → Ewing.
  5. Key translocation: t(11;22) = Ewing; t(2;13) = alveolar rhabdomyosarcoma.

In a viva, linking histomorphology + molecular marker + translocation for a single tumour earns full marks.

Lysosomal Storage Disorders — Mechanism

Lysosomal storage disorders (LSDs) share one pathogenic template:

Deficient lysosomal enzyme → substrate accumulates in lysosomes → cell swells and dysfunctions → organ failure

Lysosomes are the cell's recycling plant, using acid hydrolases at pH 4.5–5.0 to degrade glycolipids, glycoproteins, and glycosaminoglycans. When the enzyme is genetically absent or defective:
1. Partially digested substrate (lipid, sugar, protein) packs into secondary lysosomes.
2. Lysosomes distend; the cell's cytoplasm fills with pale vacuoles visible on H&E.
3. Affected cells: primarily macrophages/monocytes (RES) for lipidoses; hepatocytes + neurons for others.
4. Organs most affected: liver, spleen, brain, bone marrow.

Almost all LSDs are autosomal recessive (one functional enzyme copy usually sufficient; disease when both alleles mutant).

Diagram comparing normal lysosomal digestion with lysosomal enzyme deficiency, substrate accumulation, cell swelling, and organ dysfunction in lysosomal storage disorders.

Mechanism of Lysosomal Storage Disorders

Panel A: Normal cell with lysosome, functional acid hydrolase enzyme, substrate entry, acidic pH 4.5–5.0, and degraded recycled products.. Panel B: Enzyme-deficient lysosome with absent or defective enzyme, partially digested substrate, distended secondary lysosomes, and pale cytoplasmic vacuoles visible on H&E.. Panel C: Swollen storage macrophage/monocyte with lysosomal accumulation, organ involvement including liver, spleen, brain, and bone marrow, plus autosomal recessive inheritance icon..

Gaucher Disease, Niemann-Pick Disease & Tay-Sachs

Gaucher Disease — most common LSD

Deficient enzyme: glucocerebrosidase (acid β-glucosidase) → accumulation of glucocerebroside (glucosylceramide) in macrophages.

Morphology: Gaucher cells — large pale macrophages with a wrinkled "crinkled tissue paper" cytoplasm (glucocerebroside fibrils). Hepatosplenomegaly, bone marrow replacement → pancytopenia, bone pain, pathological fractures, "Erlenmeyer flask" deformity of distal femur on X-ray.

Types: Type 1 (non-neuronopathic, most common, Ashkenazi Jewish population) — no CNS; Types 2 & 3 — CNS involvement.

Treatment: enzyme replacement therapy (imiglucerase) — transforms prognosis of Type 1.

Niemann-Pick Disease

Deficient enzyme: sphingomyelinase → accumulation of sphingomyelin in macrophages and neurons.

Morphology: foam cells (lipid-laden macrophages) in spleen, liver, lymph nodes, bone marrow; neuronal involvement → progressive neurodegeneration. Hepatosplenomegaly + neurodegeneration in Types A/B.

Tay-Sachs Disease

Deficient enzyme: hexosaminidase A (α-subunit mutation) → accumulation of GM2 ganglioside predominantly in neurons.

Clinical: onset 3–6 months; developmental regression, hyperacusis (exaggerated startle to sound), progressive motor/cognitive decline, seizures, death by age 2–4 years.

Pathognomonic finding: cherry-red spot at the macula — the fovea centralis appears red because the surrounding ganglion cell layer (pale from lipid storage) creates a ring that contrasts with the vascular choroid shining through the thin fovea.

Epidemiology: Ashkenazi Jewish population (1:30 carrier rate); AR. No treatment; prenatal diagnosis via amniocentesis.

Four-panel diagram explaining retinoblastoma clinical signs, RB1 two-hit genetics, hereditary versus sporadic patterns, and rosette microscopy.

Retinoblastoma: Genetics, Clinical Features and Microscopy

Panel A: Child with leukocoria and strabismus; enlarged eye cutaway showing retina, vitreous body, optic nerve, and intraocular retinal tumor.. Panel B: RB1 tumour suppressor gene on chromosome 13q14; hereditary pathway with germline plus somatic hits; sporadic pathway with two somatic hits.. Panel C: Hereditary retinoblastoma 40% showing bilateral multifocal tumors, AD inheritance, and later osteosarcoma risk; sporadic retinoblastoma 60% showing unilateral unifocal tumor.. Panel D: Small round blue cells with Flexner-Wintersteiner rosette around a central lumen and Homer-Wright rosette without a true lumen..

SELF-CHECK

Bone marrow biopsy from a 30-year-old Ashkenazi Jewish woman with splenomegaly, pancytopenia, and bone pain shows large macrophages with pale wrinkled "crinkled tissue paper" cytoplasm. Which enzyme is deficient?

A. Hexosaminidase A

B. Sphingomyelinase

C. Glucocerebrosidase

D. α-L-iduronidase

Reveal Answer

Answer: C. Glucocerebrosidase

The description is classic for Gaucher cells — large macrophages with wrinkled pale cytoplasm due to glucocerebroside accumulation. The deficient enzyme is glucocerebrosidase (acid β-glucosidase). Hexosaminidase A deficiency = Tay-Sachs (cherry-red spot, neuronal); sphingomyelinase = Niemann-Pick; α-L-iduronidase = Hurler syndrome (MPS I).